Lineage Cell Therapeutics (LCTX) Stock Price & Financial Analysis
Lineage Cell Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Lineage Cell Therapeutics
What is the current stock price for LCTX?
As of the latest trading session, LCTX stock trades at $1.57. The 52-week range is $0.37–$2.09, with a day range of $1.54–$1.60.
What is the P/E ratio for LCTX?
The P/E ratio (Price-to-Earnings) for LCTX is shown in the Key Statistics section. This valuation metric helps compare Lineage Cell Therapeutics, Inc. to industry peers.
Does LCTX pay dividends?
Lineage Cell Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for LCTX?
Based on 3 analysts, the consensus for LCTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of LCTX?
Lineage Cell Therapeutics's market capitalization is $361.3M, classifying it as a small-cap company. Lineage Cell Therapeutics operates in the Healthcare sector within the Biotechnology industry.